Use of a directly conjugated monoclonal anti‐D (BRAD‐3) for quantification of fetomaternal hemorrhage by flow cytometry

Paul Lloyd-Evans(Southmead Hospital), E. Howard Taylor(St. Elizabeth Hospital in Enumclaw), Eric Austin(NHS Blood and Transplant), I. Bromelow(Merseytravel), Belinda M. Kumpel(NHS Blood and Transplant)

Transfusion

May 1, 1996

10.1046/j.1537-2995.1996.36596282587.x

Cited by 56

Related Papers

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

|Blood|2013|226

Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.

|PubMed|1994|107

Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?

|Trends in Immunology|2001|103

Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers

|Vox Sanguinis|2007|97

Human monoclonal anti‐D antibodies. I. THEIR PRODUCTION, SEROLOGY, QUANTITATION AND POTENTIAL USE AS BLOOD GROUPING REAGENTS

|British Journal of Haematology|1989|93